• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Firefly Neuroscience Inc. filed SEC Form 8-K: Leadership Update

    12/3/24 5:04:09 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology
    Get the next $AIFF alert in real time by email
    wavd20241203_8k.htm
    false 0000803578 0000803578 2024-11-30 2024-11-30
     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     

     
    FORM 8-K
     
     

     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934
     
    Date of Report (Date of earliest event reported): November 30, 2024
     
     

     
    FIREFLY NEUROSCIENCE, INC.
    (Exact Name of Registrant as Specified in Its Charter)
     
     

     
     
    Delaware
     
    001-41092
     
    54-1167364
    (State or other jurisdiction
    of incorporation)
     
    (Commission
    File Number)
     
    (IRS Employer
    Identification No.)
     
     
         
    1100 Military Road
    Kenmore, NY
     
    14217
    (Address of principal executive offices)
     
    (Zip Code)
     
    Registrant’s telephone number, including area code: 888-237-6412
     
     
    (Former name or former address, if changed since last report)
     
     

     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered pursuant to Section 12(b) of the Act:
     
             
    Title of each class
     
    Trading
    Symbol(s)
     
    Name of each exchange
    on which registered
    Common Stock, $0.0001 par value per share
     
    AIFF
     
    The Nasdaq Capital Market
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
     
    Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
     
     

     
     
    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
     
    Resignation of Executive Chairman
     
    On November 30, 2024, David Johnson resigned from his position as the Executive Chairman of Firefly Neuroscience, Inc. (the “Company”) and as a director of the board of directors of the Company (the “Board”), effective immediately. Mr. Johnson’s resignation was not the result of any disagreement between Mr. Johnson and the Company, its management, the Board or any committee of the Board on any matter relating to the Company’s operations, policies or practices, or any other matter.
     
    Appointment of Executive Chairman
     
    On December 3, 2024, the Company appointed Greg Lipschitz as the Executive Chairman of the Company, effective as of the same date.
     
    Mr. Lipschitz has served as a director of the Company since December 2022. Mr. Lipschitz has over 13 years of combined experience in private equity, merchant banking, capital markets and finance. From June 2018 to February 2024, Mr. Lipschitz served as the Vice President of Lazer Capital. Mr. Lipschitz is currently the Managing Director of Old Stone Advisors, a financial advisory firm. Mr. Lipschitz has advised on over $1 billion of transactions. Mr. Lipschitz is a Chartered Financial Analyst and received his bachelor’s degree in Business from the Richard Ivey Business School at the University of Western Ontario.
     
    Mr. Lipschitz will not be provided any additional compensation for his service as Executive Chairman of the Company, however, Mr. Lipschitz will continued to be employed by the Company pursuant to that certain Strategic Agreement, dated as of August 14, 2024, by and between Bower Four Corp. and the Company (the “Lipschitz Agreement”), pursuant to which, Mr. Lipschitz through Bower Four Corp., is entitled to receive aggregate consideration of $950,000 in shares of common stock of the Company, par value $0.0001 per share, during the term of the Lipschitz Agreement comprised of up to $316,667 of annual service credits over three years, as defined in the Lipschitz Agreement. There is no arrangement or understanding between Mr. Lipschitz and any other person pursuant to which he was appointed as Executive Chairman of the Company. There are no family relationships between Mr. Lipschitz and any of the Company’s directors, executive officers or persons nominated or chosen by the Company to become a director or executive officer of the Company.
     
     

     
     
    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
        FIREFLY NEUROSCIENCE, INC.  
    Date: December 3, 2024
    By:
    /s/ Jon Olsen
    Name:
    Jon Olsen
    Title: 
    Chief Executive Officer
     
     
     
    Get the next $AIFF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIFF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AIFF
    SEC Filings

    View All

    Firefly Neuroscience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits

    8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)

    2/4/26 4:16:04 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    SEC Form 424B5 filed by Firefly Neuroscience Inc.

    424B5 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)

    2/3/26 4:45:06 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    Firefly Neuroscience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)

    12/19/25 5:15:23 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Firefly Neuroscience Reports Third Quarter 2025 Financial Results

     – Quarterly performance characterized by higher revenues, reduced cost structure and improved bottom line – – Successful business integration drives 10.9% sequential quarter-over-quarter EEG/ERP scan volumes and 30% sequential revenue growth – KENMORE, N.Y., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today reported financial results for the three and nine months ended September 30, 2025. Business Highlights Third quarter 2025 revenue grew more than tenfold year-over-year and 30% s

    11/12/25 7:45:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America

    KENMORE, N.Y. and MIAMI, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced a new partnership with HealingMaps, the leading directory for ketamine, psychedelic-assisted therapy, and transcranial magnetic stimulation ("TMS") clinics, and Advanced Behavioral Strategies (ABS). The collaboration comes on the heels of HealingMaps and Capstone Management Group announcing their official launch of the Healing Health Alliance*, the first-of-its-kind Group Purchasing Organization ("GPO"

    9/5/25 7:55:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen 'CLEAR' Platform

    – Unlocks exciting new AI-driven brain biomarker discovery and advancement capabilities – – Substantial processing speed gains while maintaining high signal quality standards – – Comes just months after Firefly announced its acceptance into the NVIDIA Connect Program – KENMORE, Wash. and NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to unveil its new ‘CLEAR' (CLeaning EEG ARtifacts) Platform, a proprietary next-generation preprocessing techno

    8/26/25 7:45:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Menawat Arun Swarup

    4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)

    10/30/25 3:48:32 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Posner Brian M

    4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)

    10/30/25 3:47:39 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Vnook Stella

    4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)

    10/30/25 3:46:24 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Financials

    Live finance-specific insights

    View All

    Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

    Company successfully listed on Nasdaq under the symbol "AIFF" Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company's dual go-to-market strategy TORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced its financial results for the third quarter ended September 30, 2024, and provided a stockholder update. Firefly is dedicated to improving outcomes for people suffering wi

    11/14/24 5:30:18 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Leadership Updates

    Live Leadership Updates

    View All

    Stran & Company Appoints Veteran Financial Executive Brian M. Posner to its Board of Directors

    Quincy, MA, July 10, 2025 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ:SWAG) (NASDAQ:SWAGW), a leading provider of outsourced marketing solutions specializing in promotional products and loyalty incentives, today announced the appointment of Brian M. Posner, MBA, to its Board of Directors. Mr. Posner will serve as Chairman of the Audit Committee. Brian Posner brings over four decades of public company financial leadership, strategic planning, and investor relations experience to the Company. Currently, Mr. Posner serves on the Board of Directors of Firefly Neuroscience, Inc. (NASDAQ:AIFF), where he also chairs the Audit Committee. Firefly is an artificial

    7/10/25 8:00:00 AM ET
    $AIFF
    $SWAG
    Computer Software: Prepackaged Software
    Technology
    Advertising
    Consumer Discretionary

    Firefly Neuroscience Appoints Current Board Member, Greg Lipschitz, as Executive Chairman

    TORONTO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced the appointment of current director of the Board, Greg Lipschitz, as Executive Chairman, effective as of December 3, 2024. "I look forward to taking on a more active leadership role as Executive Chairman," said Greg Lipschitz, newly appointed Executive Chairman of Firefly. "I believe that Firefly is uniquely positioned at the intersection of artificial intelligence and brain health that I have l

    12/4/24 9:00:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    Firefly Neuroscience Appoints Dr. Stella Vnook to its Board of Directors

    TORONTO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced the appointment of Stella Vnook, Ph.D. to its Board of Directors, effective as of August 19, 2024. Dr. Vnook will serve as Chairperson of the Nominating Committee. Dr. Vnook brings over 25 years of experience as a distinguished pharmaceutical executive, serial entrepreneur, CEO and founder of multiple biotech companies and visionary leader with a track record of success in biotechnology and life

    9/5/24 9:00:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Firefly Neuroscience Inc.

    SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

    9/19/24 9:48:56 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Firefly Neuroscience Inc.

    SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

    8/21/24 6:07:51 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Firefly Neuroscience Inc.

    SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

    8/21/24 6:03:49 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology